Creso Pharma’s Mernova secures first sale for Ritual Sticks
Finfeed
Archived
Mar 19, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced three new purchase orders for its wholly-owned Canadian subsidiary, Mernova Medicinal Inc, with a total value of C$177,122.40 (A$183,019.55).